Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Lymphoma (Hodgkin's Disease and

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 20

Dr.

Vijay Shah
Associate Professor
Depart. Of Pediatrics
NOBEL MEDICAL COLLEGE, TEACHING
HOSPITAL
Lymphoma is a type of cancer involving cells of the
immune system, called lymphocytes.
Lymphoma is a group of cancers that affect the cells
that play a role in the immune system and primarily
represents cells involved in the lymphatic system of
the body.
Lymphoma is the 3rd most common cancer among
children in USA.
Annual incidence of 15/million children <14 yr of age.
Two broad categories of Lymphoma: HD and non
NHL.
HODGKIN DISEASE
Hodgkin's disease, is a type of lymphoma, which is
a cancer originating from white blood cells called
lymphocytes.
HD is a malignant process of the lymphoreticular
system that constitutes 6% of childhood cancers.
EPIDEMIOLOGY:
In Developing countries, the early peak occurs before
adolescence.
 A Male: Female with a ratio of 4:1 for children 3-7 yr
of age, 3:1 for children 7-9 yr of age and 1.3:1 for
children >10 yr of age.
Cause
There are no guidelines for preventing Hodgkin's lymphoma;
this is because the cause is unknown or multifactorial.
A risk factor is something that statistically increases one's
chance of contracting a disease or condition.
Risk factors for Hodgkin's lymphoma include:
Sex: male
Ages: 15–40 and over 55
Family history
History of infectious mononucleosis or infection with Epstein-
Barr virus, a causative agent of mononucleosis
Weakened immune system, including infection with HIV or the
presence of AIDS
Prolonged use of human growth hormone
Exposure to exotoxins
RYE CLASSIFICATION
Lymphocyte predominance
Mixed cellularity
Nodular sclerosis
Lymphocyte depletion
Classification systems for HD: NEW
WHO/REAL Classification
Nodular lymphocyte predominance

Classical Hodgkin lymphoma


Lymphocyte rich
Mixed cellularity
Nodular sclerosis
Lymphocyte depletion
Anaplastic large cell lymphoma Hodgkin-like
Staging classification:
 The Ann Arbor staging classification scheme is a common
one):
Stage I is involvement of a single lymph node region
(mostly the cervical region) or single extralymphatic site.
Stage II is involvement of two or more lymph node regions
on the same side of the diaphragm or of one lymph node
region and a contiguous extralymphatic site .
Stage III is involvement of lymph node regions on both
sides of the diaphragm, which may include the spleen
and/or limited contiguous extralymphatic organ or site .
Stage IV is disseminated involvement of one or more
extralymphatic organs.
Presentation of Hodgkin’s
Disease
Age: adolescents >> young child
Painless lymphadenopathy
 Progresses over weeks  months
Location
 Cervical/supraclavicular  LNS
 unilateral or bilateral 95%
 Mediastinum ± hilum

 LNs below diaphragm and spleen


 Liver, lung, bone marrow
Presentation of Hodgkin’s Disease

Systemic symptoms
 Fevers
 Night sweats “B” symptoms
 Weight loss 25%
 Pruritus

• Superior Mediastinal Syndrome (SMS)


– Orthopnea, SOB, stridor, hypoxia
•Tracheal

•Bronchial compression

•Cardiac = Oncologic Emergency


HD in 16 y/o girl HD in 9 y/o boy
 left cervical LNs, wt cough, fever, night sweats
loss Pruritus shins, + orthopnea
cough, no orthopnea

Superior Mediastinal Syndrome (SMS)


= Oncologic Emergency
HD – 9 y/o CT scan with SMS

Ant. mediastinal mass Pericardial effusion


compressing trachea; with tamponade
Pleural effusion
Superior Vena Cava (SVC) Syndrome in
10 y/o with Lymphoblastic Lymphoma
Facial swelling, plethora, cyanosis,  neck veins

Mediastinal mass: tracheal


and SVC compression
Lymphoblastic Lymphoma (T-cell, thymus)
Same boy 1 week after initial treatment
• rapid onset • rapid response
Signs and tests
Biopsy of suspected tissue, usually a lymph node
biopsy
Bone marrow biopsy
Blood chemistry tests including protein levels, liver
function tests, kidney function tests, and uric acid
level
CT scans of the chest, abdomen, and pelvis
Complete blood count (CBC) to check for anemia and
white blood count
PET scan (positron emission tomography )
Treatment depends on your age and stage of the
cancer.
Stages I and II (limited disease) can be treated with
radiation therapy, chemotherapy, or both.
Stages III is treated with chemotherapy alone or a
combination of radiation therapy and chemotherapy.
Stage IV (extensive disease) is most often treated with
chemotherapy alone.
Additional treatments depend on other symptoms.
They may include:
Transfusion of blood products, such as platelets or red
blood cells, to fight low platelet counts and anemia.
Rx,
Chemo and Radiation therapy are effective in the
treatment of HD.
HD in Ped. Involves the use of combined chemo with
or without low-dose involved field radiation therapy.
Radiation doses of 3,500-4,000 cGy.
Chemo. Agents commonly used to treat children and
adolescents with HD include:
Cyclophosphamide, procarbazine, Vincristine or
Vinblastine, Prednisone or dexamethasone,
doxorubicin, bleomycin,
decarbazine,etoposide,methotrexate and cytosine.
Combined chemotherapy
COPP: (cyclophosphamide, vincristine[oncovin],
procarbazine, and prednisone) OR ABVD:
Adriamycin, bleomycin, vinblastine, and dacarbazine
Takes between six and eight months, although longer
treatments may be required.
BEACOPP ( bleomycin, etoposide, doxorubicin,
cyclophosphamide, vincristine, procarbazine,
prednisone) used for patients with advanced stage
disease.
Antibiotics to fight infection, especially if a fever
occurs.
Prognosis:
With the right treatment, more than 90% of people
with stage I or II Hodgkin's lymphoma survive for at
least 10 years.
If the disease has spread, the treatment is more intense
but 90% of people with advanced disease survive 5
years.
Patients who survive 15 years after treatment are more
likely to later die from other causes than Hodgkin’s
disease.
Complications
Long-term complications of chemotherapy or
radiation therapy include:
Bone marrow diseases (such as leukemia)
Heart disease
Inability to have children (infertility)
Lung problems
Other cancers
Thyroid problems
Chemotherapy can cause low blood cell counts, which
can lead to an increased risk of bleeding, infection,
and anemia.
Infection should always be taken seriously during
cancer treatment.
THANK YOU!!!!

You might also like